Home/ Supplements/ Omega 3/ Steady On

Steady On

product on market Powder Allergy Research Group Safety: 99/100
99/100

This product looks safe

  • Niacin: 180mg is 5.1× the Tolerable Upper Intake Level (35mg)
  • Beta-Carotene: 7mg is 2.3× the Tolerable Upper Intake Level (3.0mg)
  • 48% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The product profile consists of basic macronutrients, including proteins, carbohydrates, and fats. There is strong evidence that these components provide essential energy and structural support for bodily functions. Due to the lack of specialized bioactive compounds, the evidence coverage for targeted therapeutic effects is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 180mg is 5.1× the Tolerable Upper Intake Level (35mg)

Beta-Carotene: 7mg is 2.3× the Tolerable Upper Intake Level (3.0mg)

Label

Product Label

Label for Steady On
Open Full PDF View on NIH DSLD →
Details

Label Data

20 Gram(s)
Serving Size
45
Servings
Other Combinations
Product Type
48%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
50 {Calories}
Calories from Fat
30 {Calories}
Total Fat
3 Gram(s) (5% DV)
Total Carbohydrates
4 Gram(s) (1% DV)
Protein
1 Gram(s) (2% DV)
Vitamin A
1680 IU (34% DV)
Vitamin C
440 mg (730% DV)
130 IU (33% DV)
Within RDA (0.2× RDA) 608 studies (A:16, B:251)
360 IU (1200% DV)
16.1× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
45 mcg (56% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)
22 mg (1470% DV)
18.3× RDA — above typical dose 76 studies (A:0, B:33)
22 mg (1290% DV)
16.9× RDA — above typical dose 13 studies (A:0, B:1)
180 mg (900% DV)
Exceeds UL by 5.1× (UL: 35 mg) 196 studies (A:5, B:63)
22 mg (1100% DV)
16.9× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
350 mcg (88% DV)
Within RDA (0.9× RDA) 226 studies (A:10, B:105)
22 mcg (370% DV)
9.2× RDA — above typical dose 139 studies (A:1, B:44)
130 mcg (43% DV)
4.3× RDA — above typical dose 27 studies (A:0, B:11)
110 mg (1100% DV)
22.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
310 mg (31% DV)
130 mg (33% DV)
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
13 mg (87% DV)
1.2× RDA — within safe limits 263 studies (A:6, B:134)
90 mcg (130% DV)
1.6× RDA — within safe limits 173 studies (A:0, B:67)
0.9 mg (45% DV)
Within RDA (1.0× RDA) 37 studies (A:0, B:11)
180 mcg (150% DV)
5.1× RDA — above typical dose 199 studies (A:1, B:55)
Potassium
45 mg (1% DV)
Exceeds UL by 2.3× (UL: 3.0 mg) 241 studies (A:5, B:97)
67 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
22 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
22 mg
Market median: 125.0mg (294 products) 38 studies (A:1, B:7)
1440 mg
Market median: 60.0mg (94 products) 13 studies (A:0, B:7)
L-Alanine
35 mg
110 mg
Market median: 500.0mg (143 products)
Market median: 2000.0mg (63 products)
110 mg
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)
Alpha-Glucan Oligosaccharide
11 mg
67 mg
Market median: 420.0mg (227 products)
Glycine
67 mg
L-Histidine
22 mg
45 mg
Market median: 17.4mg (161 products)
50 mg
Market median: 500.0mg (159 products)
180 mg
Market median: 500.0mg (193 products) 7 studies — no high-quality reviews
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
L-Phenylalanine
440 mg
L-Proline
45 mg
L-Serine
42 mg
670 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
L-Threonine
45 mg
440 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
N-Acetyl-L-Cysteine
440 mg
Glutathione
110 mg
Pancreatin
13 mg
Papain
22 mg
22 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
45 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
1.8 mg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
1.3 mg
Market median: 10.0mg (35 products) 6 studies (A:0, B:2)
Palmitic Acid
130 mg
Stearic Acid
40 mg
440 mg
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)
45 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
MSM
45 mg
Market median: 1000.0mg (2 products)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Oat Bran Rice Bran Psyllium Bran Apple Fiber natural Lemon Oil {flavoring} natural Lime Oil flavoring Sorbitol Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use As a dietary supplement, take 1 level scoop one or two times daily, mixed with desired liquid, or as directed by a healthcare practitioner.

Additional Information

Steady On is a blend of nutrients designed to provide comprehensive general nutrition, along with precursors for the formulation of neurotransmitters.* This proprietary blend is available at a fraction of the cost of all of these nutrients taken separately - all in a convenient powder form.

Variations in product color may occur.

Keep in a cool, dry place, tightly capped.

Product is sold by weight, not volume. Some settling may occur.

Rev. 007

Total Neurological Nutrient Support

Metadata

Product Details

UPC / SKU7 13947 73810 2
DSLD Entry Date2016-01-25
Product TypeOther Combinations
FormPowder
DSLD ID54482
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.